Oral mitemcinal (GM-611), an erythromycin-derived prokinetic, accelerates normal and experimentally delayed gastric emptying in conscious dogs

Clinical and Experimental Pharmacology and Physiology

Volumn 35, Issue 1, 2008, Pages 35-42

  Onoma, Mitsu ^a   Yogo, Kenji ^a   Ozaki, Ken Ichi ^a   Kamei, Kenshi ^a   Akima, Michitaka ^a   Koga, Hiroshi ^a   Itoh, Zen ^b   Omura, Satoshi ^c   Takanashi, Hisanori ^a  

^a CHUGAI PHARMACEUTICAL CO LTD   (Japan)

^b GUNMA UNIVERSITY   (Japan)

^c KITASATO INSTITUTE   (Japan)

Author keywords

Cisapride; Conscious dog; Gastric emptying; Gastrointestinal motility; Gastroparesis; GM 611; Mitemcinal

Indexed keywords

CISAPRIDE; CLONIDINE; MITEMCINAL; PARACETAMOL; PROKINETIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOG; DOSE RESPONSE; DRUG EFFECT; DUODENUM; FEMALE; FORCE TRANSDUCER; MALE; NONHUMAN; STOMACH ANTRUM; STOMACH EMPTYING; STOMACH FUNCTION; STOMACH MOTILITY; STOMACH PARESIS; TEST MEAL; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE; TRUNCUS VAGOTOMY;

ACETAMINOPHEN; ADMINISTRATION, ORAL; ANIMALS; CISAPRIDE; CLONIDINE; DISEASE MODELS, ANIMAL; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; DUODENUM; ERYTHROMYCIN; GASTRIC EMPTYING; GASTROINTESTINAL AGENTS; GASTROINTESTINAL MOTILITY; GASTROPARESIS; POSTPRANDIAL PERIOD; RECEPTORS, GASTROINTESTINAL HORMONE; RECEPTORS, NEUROPEPTIDE; STOMACH; TIME FACTORS; VAGOTOMY;

EID: 36649000020     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2007.04744.x     Document Type: Article

References (30)

1. Vandenplas Y, Hauser B, Salvatore S. Current pharmacological treatment of gastroparesis. Expert Opin. Pharmcother. 2004 5 : 2251 4.
2. Talley NJ. Review article: Functional dyspepsia. Should treatment be targeted on disturbed physiology? Aliment. Pharmacol. Ther. 1995 9 : 107 15.
3. 2 receptor blockade by antidopaminergic gastrointestinal prokinetics. Aliment. Pharmacol. Ther. 2004 19 : 379 90.
4. 13C breath tests. Dig. Dis. Sci. 1995 40 : 2200 6.
5. Fraser RJ, Horowitz M, Maddox AF, Dent J. Postprandial antropyloroduodenal motility and gastric emptying in gastroparesis: Effects of cisapride. Gut 1994 35 : 172 8.
6. Wysowski DK, Corken A, Gallo-Torres H, Talarico L, Rodriguez EM. Postmarketing reports of QT prolongation and ventricular arrhythmia in association with cisapride and Food and Drug Administration regulatory actions. Am. J. Gastroenterol. 2001 96 : 1698 703.
7. Itoh Z, Nakaya M, Suzuki T, Arai H, Wakabayashi K. Erythromycin mimics exogenous motilin in gastrointestinal contractile activity in the dog. Am. J. Physiol. 1984 247 : G688 94.
8. Peeters TL. Erythromycin and other macrolides as prokinetic agents. Gastroenterology 1993 105 : 1886 99.
9. Ōmura S, Tsuzuki K, Sunazuka T et al. Macrolides with gastrointestinal motor stimulating activity. J. Med. Chem. 1987 30 : 1941 3.
10. Tsuzuki K, Sunazuka T, Marui S et al. Motilides, macrolides with gastrointestinal motor stimulating activity. I. O-substituted and tertiary N-substituted derivatives of 8,9-anhydroerythromycin A 6,9-hemiacetal. Chem. Pharm. Bull. 1989 37 : 2687 700.
11. Li JJ, Chao HG, Wang H et al. Discovery of a potent and novel motilin agonist. J. Med. Chem. 2004 47 : 1704 8.
12. Koga H, Sato T, Tsuzuki K, Onoda H, Kuboniwa H, Takanashi H. Potent, acid-stable and orally active macrolide-type motilin receptor agonists, GM-611 and the derivatives. Bioorg. Med. Chem. Lett. 1994 4 : 1347 52.
13. Takanashi H, Yogo K, Ozaki K, Koga H, Itoh Z mura S. In vitro pharmacological characterization of mitemcinal (GM-611), the first acid-resistant nonpeptide motilin receptor agonist, in smooth muscle of rabbit small intestine. Pharmacology 2007 79 : 137 48.
14. Ozaki K, Yogo K, Sudo H et al. Effects of mitemcinal (GM-611), an acid-resistant nonpeptide motilin receptor agonist, on the gastrointestinal contractile activity in conscious dogs. Pharmacology 2007 79 : 223 35.
15. Fang J, McCallum R, DiBaise J, Schmitt C, Kipnes M. Effects of mitemcinal fumarate (GM-611) on gastric emptying in patients with idiopathic or diabetic gastroparesis. Gastroenterology 2004 126 : A483 (Abstract).
16. Kipnes M, Schmitt M, DiBaise K, Fang C, Sarosiek I. Safety of mitemcinal fumarate (GM-611) in patients with symptomatic gastroparesis. Diabetes 2004 53 : A132 (Abstract).
17. Inatomi N, Satoh H, Maki Y, Hashimoto N, Itoh Z mura S. An erythromycin derivative, EM-523, induces motilin-like gastrointestinal motility in dogs. J. Pharmacol. Exp. Ther. 1989 251 : 707 12.
18. Heading RC, Nimmo J, Prescott LF, Tothill P. The dependence of paracetamol absorption on the rate of gastric emptying. Br. J. Pharmacol. 1973 47 : 415 21.
19. Itoh Z. Motilin and clinical application. Peptides 1997 18 : 593 608.
20. Shiba Y, Mizumoto A, Inatomi N, Haga N, Yamamoto O, Itoh Z. Stimulatory mechanism of EM523-induced contractions in postprandial stomach of conscious dogs. Gastroenterology 1995 109 : 1513 21.
21. Itoh Z, Takeuchi S, Aizawa I, Couch EF. Inhibitory effect of pentagastrin and feeding natural and motilin-induced interdigestive contractions in the stomach of conscious dogs. Gastroenterol. Jpn. 1977 12 : 284 8.
22. Tanaka T, Mizumoto A, Mochiki E, Suzuki H, Itoh Z, Ōmura S. Effects of EM574 and cisapride on gastric contractile and emptying activity in normal and drug-induced gastroparesis in dogs. J. Pharmacol. Exp. Ther. 1998 287 : 712 19.
23. Gullikson GW, Virina MA, Loeffler R, Erwin WD. Alpha 2-adrenergic model of gastroparesis: Validation with renzapride, a stimulator of motility. Am. J. Physiol. 1991 261 : G426 32.
24. Garcia-Garayoa E, Monge A, Roca J, Del Rio J, Lasheras B. VB20B7, a novel 5-HT-ergic agent with gastrokinetic activity. II. Evaluation of the gastroprokinetic activity in rats and dogs. J. Pharm. Pharmacol. 1997 49 : 66 73.
25. Tanaka T, Kendrick ML, Zyromski NJ, Meile T, Sarr MG. Vagal innervation modulates motor pattern but not initiation of canine gastric migrating motor complex. Am. J. Physiol. Gastrointest. Liver Physiol. 2001 281 : G283 92.
26. Takeda M, Tsukamoto K, Yamano M, Uesaka H. Effects of SK-951, a benzofuran derivative, as a prokinetic agent in rats and dogs. Jpn. J. Pharmacol. 1999 81 : 292 7.
27. Carlson RG, Hocking MP, Courington KR, Sninsky CA, Vogel SB. Erythromycin enhances delayed gastric emptying in dogs after Roux-Y antrectomy. Am. J. Surg. 1991 161 : 31 5.
28. Orihata M, Sarna SK. Contractile mechanisms of action of gastroprokinetic agents: Cisapride, metoclopramide, and domperidone. Am. J. Physiol. 1994 266 : G665 76.
29. Gue M, Fioramonti J, Bueno L. A simple double radiolabeled technique to evaluate gastric emptying of canned food meal in dogs. Application to pharmacological tests. Gastroenterol. Clin. Biol. 1988 12 : 425 30.
30. Sato F, Marui S, Inatomi N, Itoh Z, Ōmura S. EM574, an erythromycin derivative, improves delayed gastric emptying of semi-solid meals in conscious dogs. Eur. J. Pharmacol. 2000 395 : 165 72.